Results 221 to 230 of about 57,726,953 (253)
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
The hidden cost of positivity: Ensuring integrity in scientific research. [PDF]
Lemos JRN +4 more
europepmc +1 more source
PANoptosis in the pathogenesis of myelodysplastic syndromes
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla +4 more
wiley +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
Practical guide to structuring the Discussion section in clinical and epidemiological studies. [PDF]
Leboeuf-Yde C, Gudex C.
europepmc +1 more source
Sexual harassment at medical schools: barriers to reporting and strategies for improvement - a nationwide, cross-sectional, multi-method study from Germany. [PDF]
Vogt M, Förstel M, Drossard S.
europepmc +1 more source
From individuals to communities: How genomics is transforming biodiversity conservation. [PDF]
Arantes LS +6 more
europepmc +1 more source
Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology. [PDF]
Čaušević M, Loewith R, Volarević S.
europepmc +1 more source

